BIONTECH SE ($BNTX) posted quarterly earnings results for Q4 2025 on Tuesday, March 10th. The company reported earnings of -$0.33 per share, missing estimates of -$0.19 by $0.14. The company also reported revenue of $907,167,615, beating estimates of $758,801,715 by $148,365,900.
You can see Quiver Quantitative's $BNTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIONTECH SE Hedge Fund Activity
We have seen 138 institutional investors add shares of BIONTECH SE stock to their portfolio, and 144 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 6,634,492 shares (-84.2%) from their portfolio in Q4 2025, for an estimated $631,603,638
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,746,944 shares (-36.1%) from their portfolio in Q4 2025, for an estimated $166,309,068
- PFIZER INC removed 1,658,361 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $157,875,967
- JANE STREET GROUP, LLC added 1,164,203 shares (+590.9%) to their portfolio in Q4 2025, for an estimated $110,832,125
- ALTRINSIC GLOBAL ADVISORS LLC removed 496,771 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $48,991,556
- D. E. SHAW & CO., INC. added 488,552 shares (+inf%) to their portfolio in Q4 2025, for an estimated $46,510,150
- FMR LLC added 480,114 shares (+8.8%) to their portfolio in Q4 2025, for an estimated $45,706,852
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIONTECH SE Analyst Ratings
Wall Street analysts have issued reports on $BNTX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/10/2025
- Morgan Stanley issued a "Overweight" rating on 10/10/2025
To track analyst ratings and price targets for BIONTECH SE, check out Quiver Quantitative's $BNTX forecast page.
BIONTECH SE Price Targets
Multiple analysts have issued price targets for $BNTX recently. We have seen 5 analysts offer price targets for $BNTX in the last 6 months, with a median target of $131.0.
Here are some recent targets:
- Asad Haider from Goldman Sachs set a target price of $142.0 on 01/16/2026
- Robert Burns from HC Wainwright & Co. set a target price of $140.0 on 11/10/2025
- David Dai from UBS set a target price of $117.0 on 11/06/2025
- Jessica Fye from JP Morgan set a target price of $120.0 on 10/23/2025
- Terence Flynn from Morgan Stanley set a target price of $131.0 on 10/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
